Personalized Medicine

Advances in Personalized Medicine and Immuno-oncology

Dr. Steve O’Day discusses the current state of cancer treatments, which focuses less on standard chemotherapy and has begun relying more on targeted therapies and immune-oncology.

Steven O’Day, MD
Video Categories: Personalized Medicine

Precision Medicine’s Impact on Patient Care

Dr. S. Yosuf Zafar provides an overview of the advancement of precision medicine and points out the importance of making sure treatment decisions are in line with the patient’s goals.

S. Yosuf Zafar, MD
Video Categories: Personalized Medicine

Personalized Medicine’s Impact on Cancer Care

Dr. Jorge Cortes provides examples of how personalized or precision medicine has positively impacted the approach to cancer care, citing the benefits of FLT3 inhibitors, IDH inhibitors, and MEK inhibitors, and other targeted treatments.

Jorge Cortes, MD
Video Categories: Personalized Medicine

Improving the Standard of Care

Dr. Jorge Cortes discusses how to improve the current standard of care by better utilizing the drugs and treatments that are already available.

Jorge Cortes, MD
Video Categories: Personalized Medicine

How Does the Precision Medicine Revolution Affect Cancer Care?

Dr. Alex Adjei shares an example of how precision medicine has drastically improved the quality of life for many cancer patients, but stresses the need to find more and better approaches to treating various cancer types.

Alex A. Adjei, MD, PhD, FACP
Video Categories: Personalized Medicine

The Status of the Standard of Care for Cancer Patients

Dr. Alex Adjei discusses how the standard of care for cancer patients has improved overt he last few years, but there is still a great need for new treatments designed to help a broader range of cancer patients.

Alex A. Adjei, MD, PhD, FACP
Video Categories: Personalized Medicine

Precision Medicine for CLL

Dr. Jennifer R. Brown deliberates on the state of personalized medicine in relation to CLL. She explains that the targeted drugs currently used for CLL actually work for most patients, rather than just a subgroup. Also, CLL therapies are now generally in pill form and well tolerated with few side [ Read More ]

Jennifer Brown, MD, PhD
Video Categories: Personalized Medicine

Beginnings of Personalized Medicine for Myeloma

Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.

Ajai Chari, MD
Video Categories: Personalized Medicine

The Global Challenge of Personalized Medicines

Dr. Stainthorpe explains that when it comes to bringing personalized medicines to fruition, the challenge is the same worldwide. It is an effort that requires better understanding of disease pathways and markers as well as improved diagnostics.

Andrew Stainthorpe, PhD
Video Categories: Personalized Medicine

How to Better Establish Clinical Utility for Tests in Personalized Medicine

Dr. Gary Palmer discusses the different profile of tumors and how to make findings as general as possible to better treat the patient.

Gary Palmer, MD
Video Categories: Personalized Medicine

Sign me up!
Friends link: prep4certs
070-411 Braindumps
VCP-550 Braindumps
70-483 Braindumps
HP2-K38
642-997
PK0-003
BH0-013
640-875
C4040-129
JN0-332
E20-547
70-462 Braindumps
400-101 Braindumps
070-461 Braindumps